Abbott (ABT) says Alere's (ALR) SEC filing doesn't alleviate concerns - Bloomberg
Get access to the best calls on Wall Street with StreetInsider.com's Ratings Insider Elite. Get your Free Trial here.
Abbott (NYSE: ABT) says Alere's (NYSE: ALR) SEC filing doesn't alleviate concerns, according to Bloomberg, citing a company spokesperson. Abbott notes concerns over "business controls" and other practices.
Abbott believes Alere failed to adequately explain the delay to its SEC filing.
Alere 'refuses' to provide details surrounding several business issues, Abbott noted.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- St. Jude Medical (STJ) Shareholders Approve Abbott (ABT) Merger
- Ritter Pharmaceuticals (RTTR) Prices 2.13M Share Common Offering for Proceeds of $5M
- VSE Corp. (VSEC) Reports Q3 EPS of $0.65
Create E-mail Alert Related CategoriesMergers and Acquisitions, Trader Talk
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!